The severity of clinical manifestations tends to be related to the presence of anti-HSP70 and anti-recoverin autoantibodies in cases of ocular toxoplasmosis, while in patients with CNS involvement, they may have a protective role. This evidence concerns the gene RCVRN and ocular toxoplasmosis.